• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls N-acyl amines
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty amides N-acyl amines

4-(Cyclohexylamino)-4-oxobutanoic Acid (CAS 21451-32-1): Properties, Applications, and Market Insights

4-(Cyclohexylamino)-4-oxobutanoic acid (CAS 21451-32-1) is a specialized organic compound with a unique molecular structure that combines a cyclohexyl group and a butanoic acid derivative. This chemical has garnered significant attention in recent years due to its versatile applications in pharmaceutical research, material science, and specialty chemical synthesis. The compound's IUPAC name reflects its structural features: a cyclohexylamine moiety attached through an amide linkage to a succinic acid derivative.

The growing interest in 4-(Cyclohexylamino)-4-oxobutanoic acid derivatives stems from their potential as building blocks for more complex molecules. Researchers have particularly focused on its role in developing novel pharmaceutical intermediates, with recent studies exploring its use in creating targeted drug delivery systems. The compound's balanced lipophilic-hydrophilic properties make it valuable for designing molecules with improved bioavailability, a key concern in modern drug development.

From a chemical perspective, 4-(Cyclohexylamino)-4-oxobutanoic acid exhibits interesting physical properties. The compound typically appears as a white to off-white crystalline powder with moderate solubility in polar organic solvents. Its melting point ranges between 120-125°C, and it demonstrates stability under normal storage conditions. These characteristics make it particularly useful for laboratory applications where consistent purity and stability are required.

Recent advancements in green chemistry have brought new attention to compounds like 4-(Cyclohexylamino)-4-oxobutanoic acid. Scientists are exploring more sustainable synthesis routes that reduce environmental impact while maintaining high yields. This aligns with current industry trends toward eco-friendly production methods, answering frequent search queries about "sustainable chemical synthesis" and "green pharmaceutical intermediates."

The pharmaceutical industry represents the primary application area for CAS 21451-32-1. Its structural features make it valuable for creating analogs of bioactive molecules, particularly in neurological and metabolic disorder research. Recent patent literature reveals growing interest in using this compound as a precursor for central nervous system-targeted therapeutics, addressing common search terms like "CNS drug development" and "neuropharmaceutical intermediates."

Material science applications of 4-(Cyclohexylamino)-4-oxobutanoic acid are emerging as another important research direction. The compound's ability to form stable hydrogen bonds and its amphiphilic nature make it suitable for creating specialized polymers and surface modifiers. These applications respond to frequent searches about "advanced material additives" and "functional polymer components."

Analytical characterization of 4-(Cyclohexylamino)-4-oxobutanoic acid typically involves techniques like HPLC, NMR spectroscopy, and mass spectrometry. Quality control parameters for commercial samples usually specify minimum purity levels of 97-98%, with strict limits on residual solvents and related substances. These specifications address professional queries about "chemical purity standards" and "analytical methods for specialty chemicals."

The global market for 4-(Cyclohexylamino)-4-oxobutanoic acid has shown steady growth, driven by increasing R&D investment in pharmaceutical and specialty chemical sectors. Market analysts note particular demand from North America and Asia-Pacific regions, where innovation in drug discovery is most active. This market insight responds to commercial search terms like "chemical market trends" and "specialty compound suppliers."

Handling and storage recommendations for CAS 21451-32-1 follow standard laboratory chemical protocols. The compound should be stored in tightly sealed containers at room temperature, protected from moisture and direct sunlight. These practical details answer common user questions about "chemical storage best practices" and "laboratory safety guidelines."

Future research directions for 4-(Cyclohexylamino)-4-oxobutanoic acid may explore its potential in biotechnology applications and as a scaffold for diagnostic agents. The compound's structural flexibility allows for numerous modifications, making it a valuable tool for medicinal chemistry innovation. This forward-looking perspective addresses trending searches about "next-generation chemical building blocks" and "innovative pharmaceutical precursors."

For researchers and industry professionals seeking detailed technical information about 4-(Cyclohexylamino)-4-oxobutanoic acid, comprehensive spectral data and synthetic protocols are available through scientific literature and chemical databases. These resources respond to specialized queries about "chemical characterization data" and "synthetic methodology optimization."

• 52558-70-0(Butanoic acid,4-[(1-oxododecyl)amino]-)
• 52558-71-1(Butanoic acid,4-[(1-oxooctadecyl)amino]-)
• 2014-58-6(6-Aminocaproic Acid Dimer)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)